Puma Biotechnology | PBYI - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amgen USD 19.52B 1.37B 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Exelixis USD 29.62M 4.27M 2025-12
Gilead Sciences USD 715M 93M 2025-12
Glaxosmithkline GBP 20.72B 346.14M 2025-12
Incyte USD 228.62M 1.41B 2026-03
MacroGenics USD 4.79M 1.15M 2025-12
Moderna USD 161M 156M 2026-03
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.51B 734M 2026-03
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Takeda JPY 467.59B 28.61B 2025-12
TG Therapeutics USD 61.64M 72.38M 2025-09
Ultragenyx Pharmaceutical USD 31M 9.57M 2025-12
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03